Ketone drink enhances therapeutic efficacy in prostate cancer by targeting EZH2.
Yum C, Schaefer RA, Wang R, Wang TY, Lu X, Liu Q, Ren Y, Meng Q, Yang Y, Zhang X, Xiong Y, Yu X, Zhang X, Jin J, Dong X, Yi Y, Yang R, Cao Q.
Yum C, et al. Among authors: jin j.
Oncogenesis. 2025 Jul 12;14(1):24. doi: 10.1038/s41389-025-00567-0.
Oncogenesis. 2025.
PMID: 40651983
Free article.